thanks. ill check it out

New Post Public Reply Private Reply Replies (1) Message Board
joey68 BionicBen #122
4,707
thanks. ill check it out

The MaryJane Group, Inc. (MJMJ) Stock Research Links

MJMJ Board Company Profile Buy Rating Time & Sales News Filings Financials
View My Board Here:
http://investorshangout.com/Joeys-Investment-Board-91611/


Invite Only

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.

Disclaimer:
As used herein, the terms "You" and "Your" shall mean you, individually, the reader, and each other party on whose behalf you may use the contained information at any time.
All references to "My", "I", and “The writer of the above post” shall refer to the creator of the username Joey68.

Do NOT invest unless you are prepared to sustain a total loss of the money you have invested plus any commission or other transaction charges.

There is a very high degree of risk involved in trading and investing. Past results are not indicative of future returns. I assume no responsibility for your trading and investment results. You should NOT rely on the information in the above post to make any decision or take any action.

ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are OPINION and NOT fact and are for entertainment purposes only. Do your own research and make your own decisions based on your own conclusions.
ALL OF MY STATEMENTS, including but not limited to, POSTS, MESSAGES, PRIVATE MESSAGES, and RESPONSES are NOT advice, and are NOT designed to substitute the expertise and judgment of a professional. It is your responsibility to seek investment advice during all stages of your investments. It is your responsibility to evaluate the accuracy, completeness and usefulness of the information in the above post.
I am NOT a professional.
I do NOT work for you.
My posts are NOT investment advice. I am not paid to post.
There is no correlation between the number of posts I write per day and your assumed success of a company.
It is NOT my responsibility to inform you of my own personal investment decisions.
It is NOT my responsibility to inform you when it is time for you to buy, hold, and/or sell a position.
I have no control over, and am not responsible for the actions of others who copy, store, edit, change, prepare any derivative work of or alter in any way any of the content provided in my posts.
Errors and Omissions expected. The writer of the above post accepts no liability or responsibility for any errors or omissions contained in the above post or contained within this Disclaimer.
The writer of the above post shall NOT accept any liability for the accuracy or completeness of the information contained in the above post, for any reliance placed by any person on the information contained in the above post, or for any damage or loss, however caused, in connection with the use or reliance on any information contained in the above post.
The above post may contain links to websites owned and operated by third parties. These links are provided for informational purposes only and are NOT endorsed by the writer of the above post. The writer of the above post has no control over the contents of any linked website and bears no responsibility for the accuracy, legality, or content of the external site or for that of subsequent links.
YOU ACCESS ALL LINKS ENTIRELY AT YOUR OWN RISK.
The writer of the above post makes no warranties or representations, express or implied about such linked websites, the third parties they are owned and operated by, or the information contained on these websites.
The writer of the above post accepts no liability for any damage or loss, however caused, in connection with the use of or reliance on any information, material, products, or services contained on or accessed through any such linked websites.

There is a VERY HIGH degree of RISK involved in trading and investing. Only invest what you can afford to lose.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

NOTHING NINE's Global Ambitions: Paris Show's Impact

Updated Category News Views 58

Paris: Stage or Launchpad? You’d think walking that catwalk in Paris is the holy grail—fashion's own illustrious red carpet. But when you're Chloe, founder of NOTHING NINE, the real hustle kicks off once the lights dim. On 29th September 2026, this designer brand strutted its stuff at one of the grandest venues, Les Invalides, part of the prestigious Paris Fashion...

Continue Reading
Temu Partners with Recyclia to Drive EPR Compliance Boost

Updated Category News Views 65

Temu and Recyclia: Building a Sustainable Marketplace Get this: Temu, the e-commerce giant you've heard trumpeting about affordable goods like some digital bazaar, is diving deeper into sustainability waters with a partner that knows a thing or two about waste. This time, they've linked up with Recyclia over in Spain. The duo's focus? Helping marketplace sellers meet the...

Continue Reading
Medline's Decade-Long WRAP Partnership: More Than Labels

Updated Category News Views 28

A Decade of Trust and Responsibility Here we go, folks—Medline is toasting 10 years with WRAP, and this ain't just fluffy PR spin. When two big players like these lock arms over responsible manufacturing, it's a signal worth paying attention to, and not just for the ethics alone. Production practices that prioritize transparency and worker rights have ramifications...

Continue Reading
SUNON's Approach to AI-Driven Workspaces Debuted at ORGATEC

Updated Category News Views 68

SUNON's Unique Spin on Future Workspaces The world of workplace solutions is buzzing with ideas on how to blend smart tech with soulful spaces. This year, SUNON is hitting ORGATEC 2026 in Cologne with a bold approach that stitches AI, nature, and circular design right into the fabric of office life. They’re not just setting up shop; they’re promising a peek into a...

Continue Reading
RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 277

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
CStone's CS2009: A Leap in Cancer Treatment Validated

Updated Category News Views 43

CStone's Game-Changer: CS2009 in the Spotlight CStone Pharmaceuticals just pulled a rabbit out of a hat at the ESMO 2026 Congress, showcasing the clinical might of their CS2009. This ain't just another hype train, folks. We're talking about a trispecific antibody targeting PD-1, VEGF, and CTLA-4. With data rolled out from over 300 patients, this compound promises a...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 219

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
Artprice Champions Creative Freedom with AI in 2026

Updated Category News Views 78

AI and the Creative Reawakening As the autumn of 2026 rolls in, publishing circles are buzzing over artificial intelligence's role in artistry. Weekly updates hailing rejection, tolerance, or adaptation of AI in writing stir the pot. Yet, Artprice by Artmarket stands out by anchoring creative freedom and responsibility in the spotlight. Grounded on an initiative launched...

Continue Reading
Sirha Lyon® 2027: A New Chapter in Foodservice

Updated Category News Views 54

A Bold Step Forward There's a hearty aroma wafting from Lyon this January, and it's not just from the local gastronomy. Sirha Lyon® is queuing up for its 23rd edition, promising to turn the Foodservice and Hospitality sectors on their heads. Nearly 150,000 square meters of exhibition space packed to the rafters with over 4,300 exhibitors—this ain't your average trade...

Continue Reading
OncoHost's Research Links TKI Sensitivity to Biology

Updated Category News Views 75

Cracking the Code on TKI Sensitivity When it comes to medicine, sometimes the trickiest part is knowing which button to push—especially in the high-stakes world of metastatic renal cell carcinoma (mRCC). OncoHost just dropped a bombshell at the ESMO 2026 Congress about their new plasma proteomics model that lets us peer into what makes some patients click with Tyrosine...

Continue Reading

Top 5 Most Recently Viewed Articles

Canon Teams with Amazon to Combat Counterfeit Toner Sales

Updated Category News Views 181

Back in 2024, Canon Inc. teamed up with Amazon.com to file a major lawsuit against counterfeit toner cartridges sold online. This wasn’t just some corporate handshake; it was Canon going all-in to protect their brand and customer trust. You know how it goes when the digital marketplace gets flooded with knockoffs—brands start sweating bullets over customer safety and...

Continue Reading
Smilegate and Absurd Ventures Unite for Epic Game Adventure

Updated Category News Views 161

Smilegate and Absurd Ventures Collaborate on New AAA Game In an exciting development for the gaming community, Smilegate has confirmed a partnership with Absurd Ventures to publish a highly anticipated AAA open-world game. This game is set within the intriguing universe known as A BETTER PARADISE, which was shaped by the creative vision of Dan Houser, the former Grand...

Continue Reading
Advantech Launches AOM-5721: Powering the Future of AI

Updated Category News Views 194

Innovative Launch by Advantech Advantech, a renowned leader in edge computing and AI solutions, has introduced the AOM-5721, an advanced SMARC-based Arm Computer-on-Module driven by the Qualcomm Dragonwing™ QCS6490 System on Chip (SoC). This launch symbolizes a significant leap in industrial, commercial, and medical applications, harnessing Advantech's remarkable...

Continue Reading
Insights and Expectations for Brunswick's Upcoming Earnings

Updated Category News Views 77

What Investors Should Anticipate from Brunswick's Earnings Brunswick (NYSE: BC) is set to release its quarterly earnings report soon, generating anticipation among investors. Analysts expect Brunswick to report an earnings per share (EPS) figure around $1.20. The market buzz is centered on whether they will exceed this estimate and what guidance will be provided for the...

Continue Reading
Kellanova Surpasses Expectations with Solid Sales Growth

Updated Category News Views 85

Kellanova's Recent Success in the Food Industry Kellanova, the innovative packaged food company known for brands like Pringles and Cheez-It, has recently made headlines by exceeding Wall Street expectations in its quarterly sales. The company's strong performance was highlighted in its third-quarter report, which displayed impressive resilience despite the backdrop of...

Continue Reading